Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
85
days
Histone modifications across cancers: mechanisms, therapy and clinical translation
Authors
Pengde Lu; Yau-Tuen Chan; Chun-Fung Kwok; Qiucheng Li; Zhuofeng Jiang; Lin Xu; Zixin Feng; Hongchao Yuan; Jiaqi Zou; Yunqing Xun; Tung-Leong Fong; Chi-Ming Che; Ning WangShow moreShow less
Affiliations
1. School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong S.A.R.,, P. R. China; 2. State Key Laboratory of Synthetic Chemistry, Department of Chemistry, The University of Hong Kong, Hong Kong, China; 3. Laboratory for Synthetic Chemistry and Chemical Biology Limited, Hong Kong Science Park, Hong KongShow moreShow less
202
days
Navigating luminal heterogeneity: etiology-based proteogenomic subtyping for targeted treatment strategies in breast cancer
Authors
Ya-Hsuan Chang; Yi-Ju Chen; Zhi-Jie Hong; Yi-Jing Hsiao; Kuen-Tyng Lin; Guo-Shiou Liao; Sheng-Fang Su; Ze-Shiang Lin; Huei-Wen Chen; Chia-Li Han; Eric Sheng-Wen Chen; Yin-Chen Hsu; Yan-Ming Chen; Hao Fang; Hao-Chin Yang; Yan-Si Chen; Chien-Yu Lin; Hsiang-En Hsu; Ching-Hung Lin; Pin-Lian Jiang; Pei-Shan Wu; Ching-Wen Chen; Chen-Ting Hung; Ethan Wu; Wei-Tzu Chiu; Fan-Ni Hsing; Tsai-Pei Liu; Chia-Yu Wang; Yu-Tai Wang; Chang-Wei Yeh; Ki-Hok Liao; Ana I Robles; Henry Rodriguez; Show-Ling Yang; Mien-Chie Hung; Yen-Shen Lu; Hsuan-Yu Chen; Sung-Liang Yu; Jyh-Cherng Yu; Yu-Ju ChenShow moreShow less
Affiliations
1. Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan; 2. Institute of Statistical Science, Academia Sinica, Taipei, Taiwan; 3. Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan; 4. Institute of Chemistry, Academia Sinica, Taipei, Taiwan; 5. Department of Surgery, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan; 6. Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan; 7. Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan; 8. Graduate Institute of Toxicology, National Taiwan University College of Medicine, Taipei, Taiwan; 9. Master Program in Clinical Genomics and Proteomics, College of Pharmacy, Taipei Medical University, Taipei, Taiwan; 10. Department of Medical Oncology, Cancer Center Branch, National Taiwan University Hospital, Taipei, Taiwan; 11. Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; 12. Department of Chemistry, National Taiwan University, Taipei, Taiwan; 13. National Center for High-performance Computing, National Institutes of Applied Research, Hsinchu, Taiwan; 14. Office of Cancer Clinical Proteomics Research, National Cancer Institute, National Institutes of Health, Rockville, USA; 15. Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan; 16. Graduate Institute of Biomedical Sciences, Cancer Biology and Precision Therapeutics Center, Center for Molecular Medicine, China Medical University, Taichung, Taiwan; 17. Ph.D. Program in Microbial Genomics, National Chung Hsing University, Taichung, Taiwan; 18. Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, TaiwanShow moreShow less
95
days
Multimodal sequencing identifies synergistic mechanisms driving resistance to neoadjuvant nivolumab treatment in hepatocellular carcinoma
Authors
Fanhong Zeng; Jiaxin Guo; Zheng Zeng; Vanilla Xin Zhang; Yu-Man Tsui; Po-Man Li; Abdullah Husain; Qingyang Zhang; Joyce Man-Fong Lee; Tan-To Cheung; Daniel Wai-Hung Ho; Irene Oi-Lin NgShow moreShow less
Affiliations
1. Department of Pathology, The University of Hong Kong, Hong Kong, China; 2. State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, China; 3. Department of Surgery, The University of Hong Kong, Hong Kong, ChinaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days